The association between new and established cardiovascular serum markers.

The association between new and established serum markers in cardiovascular disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28872

Enrollment

120

Registered

2005-09-12

Start date

2004-11-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Venous blood sample.

Eligibility

Inclusion criteria

Inclusion criteria: Groups of AMI, SAP, UAP and controls will be formed (n=120). All participants will donate a venous blood sample at inclusion, and after 6 and 12 months. Marker concentration will be evaluated in these blood samples.

Exclusion criteria

Exclusion criteria: 1. Unable to give informed consent; 2. CVD < 6 months; 3. Auto-immune diseases; 4. Malignancies; 5. Renal insufficiency (< 40 ml/min Creat clearance).

Design outcomes

Primary

Measure	Time frame
(Recurrent) cardiovascular disease, e.g. MI, SAP, UAP, mortality.	—

Contacts

Public ContactM. Lobbes

University Hospital of Maastricht, Department of Radiology, P.O. Box 5800

mlob@rdia.azm.nl+31 (0)43 3874910

Outcome results